THE NICKLES GROUP, LLC for CSL BEHRING LLC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to orphan drug tax credit.
Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHEL JONES HENSLER | — |
| EMILY PORTER | — |
Health Issues HCR
Monitored issues related to prescription drug pricing. H.R. 2296, FAIR Drug Pricing Act of 2019. Monitored S. 1895, Lower Health Care Costs Act of 2019, as it relates to pricing transparency and drug pricing. H.R. 2113, Prescription Drug STAR Act.
Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY HUGHES | — |
| EMILY PORTER | — |
| MARY BETH SAVARY TAYLOR | — |
Medicare/Medicaid MMM
Issues related to home infusion and DME self-administered therapies. Issues regarding reimbursement of drugs, biologics and plasma therapies. Issues pertaining to drugs listed on the Self-Administered Drug list. H.R. 2296, FAIR Drug Pricing Act of 2019. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. H.R. 2113, Prescription Drug STAR Act.
Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY HUGHES | — |
| EMILY PORTER | — |
| MARY BETH SAVARY TAYLOR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.